Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Chinese Patent Office
UBS
McKinsey
Daiichi Sankyo
Farmers Insurance
Teva
US Department of Justice
McKesson

Generated: June 18, 2018

DrugPatentWatch Database Preview

TALWIN 50 Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Talwin 50, and what generic alternatives are available?

Talwin 50 is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in TALWIN 50 is pentazocine hydrochloride. There are five drug master file entries for this compound. Additional details are available on the pentazocine hydrochloride profile page.
Summary for TALWIN 50
US Patents:0
Applicants:1
NDAs:1
Clinical Trials: 1
Formulation / Manufacturing:see details
DailyMed Link:TALWIN 50 at DailyMed
Drug patent expirations by year for TALWIN 50

US Patents and Regulatory Information for TALWIN 50

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us TALWIN 50 pentazocine hydrochloride TABLET;ORAL 016732-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Teva
Deloitte
Merck
Daiichi Sankyo
Covington
Moodys
Boehringer Ingelheim
Queensland Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.